|
|
Posted by Elaine Moore Jan 13, 2007 |
Environmental agents have long been suspected of contributing to the development and disease course of the autoimmune vascular disease Wegener's granulomatosis. Wegener's granulomatosis is a chronic autoimmune condition that causes inflammation of blood vessels, resulting in a condition of vasculitis. Vasculitis blocks blood flow to the organs affected by these vessels and eventually leads to destruction of affected tissues. Wegener's granulomatosis primarily involves the respiratory organs and the kidneys.
According to researchers, the sporadic occurrence, lack of familial or genetic associations, and rising incidence of Wegener's granulomatosis suggest possible exposure to environmental agents as causing or contributing to this disease. Researchers from the University of Pennsylvania in Philadelphia have identified a cluster of cases in the Dublin, Pennsylvania region that they are studying in an effort to pinpoint these environmental causes.
By studying hospital records and patient contacts, researchers have located 7 cases that have occurred within a 10-mile radius of an Environmental Protection Agency (EPA) Superfund toxic waste site during a three-year period.
The area under investigation includes approximately 50,000 individuals. Studies of this area have identified several toxins at or above the "action level" including trichloroethylene (TCE), vinyl chloride, methyl tertiary-butyl ether (MTBE), dichloroethane (DCE), and chromic acid from several industrial waste sites within the area.
Interviews with the patients with Wegener's granulomatosis identified in the study showed that these patients reported a total of greater than 30 possible chemicals exposures, including exposures to the chemicals mentioned above. Three of 5 patients had well water exposing them to industrial runoff that required EPA intervention. Additional phone interviews of individuals living in this region showed that mercury and possibly lead exposure were positively associated with Wegener's granulomatosis compared to the control group. A prior history of allergy was also associated with disease development.
The researchers conclude that heavy metal exposure and a prior history of allergy may contribute to Wegener's granulomatosis. Other suspected environmental triggers currently under investigation include aromatic hydrocarbons, silica, farming, prior respiratory infections especially those with Staphylococcus aureus, drug allergy or reaction, and occupational solvent exposures.
In a related study, Ohio researchers postulated that an inhaled agent may be responsible for Wegener's granulomatosis because of its inclination to affect the nasal passages and other respiratory organs. By investigating environmental exposures experienced by patients within the year prior to their diagnosis and comparing them to other people in the region unaffected by Wegener's, the researchers found that there was no seasonal trend to suggest environmental allergens as a cause. However, the patients with Wegener's granulomatosis reported a higher incidence of exposure to particulate materials from construction and occupational exposure to pesticides.
In November 2006 Swedish researchers reported an increased incidence of Wegener's granulomatosis. Whether this increase is related to improved diagnostic tests, particularly the introduction of tests to measure antineutrophilic cytoplasmic antibodies (ANCA) or an increased incidence of disease remains uncertain. In the meantime researchers at the University of Pennsylvania continue to pursue their efforts to confirm the environmental triggers of Wegener's granulomatosis. For more information on ongoing clinical trials or participation see http://www.med.upenn.edu/rheum/clintrials/wegeners/ct1.html.
Resources:
Albert D, Clarkin, C, Komoroski, J, Brensinger CM, and Berlin JA, Wegener's granulomatosis: Possible role of environmental agent in its pathogenesis, Arthritis Rheum 2004 Aug 15;51(4): 656-664.
Albert DA, Albert AN, Vernace M, Sebastian JK, Hsia EC, Analysis of a cluster of cases of Wegener granulomatosis, J Clin Rheumatol, 2005 Aug;11(4): 188-193.
Duna GF, Cotch MF, Galperin C, Hoffman DB, and Hoffman GS, Wegener's granulomatosis: role of environmental exposures, Clin Exp Rheumatol 1998 Nov-Dec; 16(6): 669-674.
Wegener's granulomatosis fact sheet, National Institute of Allergy and Infectious Diseases, http://www3.niaid.nih.gov/healthscience/healthtopics/wegener/default.htm